HeartSciences Net Income 2022-2024 | HSCS
HeartSciences net income from 2022 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| HeartSciences Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-6 |
| 2022 | $-5 |
| 2021 | $-2 |
| HeartSciences Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-01-31 | $-2 |
| 2023-10-31 | $-2 |
| 2023-07-31 | $-1 |
| 2023-04-30 | $-2 |
| 2023-01-31 | $-1 |
| 2022-10-31 | $-2 |
| 2022-07-31 | $-2 |
| 2022-04-30 | $-2 |
| 2022-01-31 | $-1 |
| 2021-10-31 | $-1 |
| 2021-07-31 | $-1 |
| 2021-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.000B |
| HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.221B | 21.82 |
| Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
| Axonics (AXNX) | United States | $3.394B | 0.00 |
| 10x Genomics (TXG) | United States | $3.206B | 0.00 |
| Enovis (ENOV) | United States | $3.022B | 22.96 |
| Azenta (AZTA) | United States | $2.872B | 234.09 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.135B | 94.68 |
| Schrodinger (SDGR) | United States | $1.688B | 0.00 |
| Omnicell (OMCL) | United States | $1.246B | 30.48 |
| Phreesia (PHR) | United States | $1.154B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Talkspace (TALK) | United States | $0.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| American Well (AMWL) | United States | $0.156B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.136B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| Outset Medical (OM) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.115B | 4.91 |
| 111 (YI) | China | $0.084B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |